GPC1 and prion disease: Targeting of both prions through glypican-1 facilitates favorable interaction of PrPSc with PrPc within membrane rafts, which are believed to be the conversion sites of PrPc to PrPSc, suggesting a critical role of glypican-1 in the pathogenesis of prion disease [243].